OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Comparative evaluation of authorized drugs for treating Covid‐19 patients
Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 38
Towhidul Islam, Moynul Hasan, Mohammad Saydur Rahman, et al.
Health Science Reports (2022) Vol. 5, Iss. 4
Open Access | Times Cited: 38
Showing 26-50 of 38 citing articles:
Molecular Docking and ADME-TOX Profiling of Moringa oleifera Constituents against SARS-CoV-2
Hellen Cris Araújo Souza, Maycon Douglas Araújo Souza, Cássio Silva Sousa, et al.
Advances in respiratory medicine (2023) Vol. 91, Iss. 6, pp. 464-485
Open Access | Times Cited: 2
Hellen Cris Araújo Souza, Maycon Douglas Araújo Souza, Cássio Silva Sousa, et al.
Advances in respiratory medicine (2023) Vol. 91, Iss. 6, pp. 464-485
Open Access | Times Cited: 2
Adsorption Behavior of Remdesivir Onto Aging Polypropylene Microplastics: Worse Criminal Syndicates
Lu Liu, ChunRui Liu, Fandi Nie, et al.
(2024)
Closed Access
Lu Liu, ChunRui Liu, Fandi Nie, et al.
(2024)
Closed Access
Newer Oral Antiviral for the Treatment of COVID-19 Infection
Sonia Singh, Drishty Surati, Madhav Kumar Savaliya, et al.
Journal of Pharmaceutical Research International (2024) Vol. 36, Iss. 9, pp. 30-37
Open Access
Sonia Singh, Drishty Surati, Madhav Kumar Savaliya, et al.
Journal of Pharmaceutical Research International (2024) Vol. 36, Iss. 9, pp. 30-37
Open Access
Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A Retrospective Study
Wei Yang, Weiting Zhang, Jing Zhou, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 12, pp. 102583-102583
Open Access
Wei Yang, Weiting Zhang, Jing Zhou, et al.
Journal of Infection and Public Health (2024) Vol. 17, Iss. 12, pp. 102583-102583
Open Access
From infected to recovered: the mediating role of sleep quality between self-compassion, social support and COVID-19 psychosomatic symptoms
Outong Chen, Fang Guan, Chengqing Zhan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
Outong Chen, Fang Guan, Chengqing Zhan, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access
Antiviral Activity Against SARS-CoV-2 Variants Using in Silico and in Vitro Approaches
Hee-Jung Lee, Hanul Choi, Aleksandra Nowakowska, et al.
The Journal of Microbiology (2023) Vol. 61, Iss. 7, pp. 703-711
Closed Access | Times Cited: 1
Hee-Jung Lee, Hanul Choi, Aleksandra Nowakowska, et al.
The Journal of Microbiology (2023) Vol. 61, Iss. 7, pp. 703-711
Closed Access | Times Cited: 1
Exploring the potential of FDA approved anti-diabetic drugs for repurposing against COVID-19: a core combination of multiple computational strategies and integrated artificial intelligence
Nusrat Shafiq, Aqsa Jannat, Huma Munir, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6556-6576
Closed Access | Times Cited: 1
Nusrat Shafiq, Aqsa Jannat, Huma Munir, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 13, pp. 6556-6576
Closed Access | Times Cited: 1
How to tackle single target gene positive results of SARS‐CoV‐2 real‐time PCR: A cross‐sectional study
Nazanin Zahra Shafiei Jandaghi, Forough Tavakoli, Jila Yavarian, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 1
Nazanin Zahra Shafiei Jandaghi, Forough Tavakoli, Jila Yavarian, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 1
Using nanomaterials to address SARS-CoV-2 variants through development of vaccines and therapeutics
Maria Victoria Hangad, Sarah Keshvani, Niya Kelpin, et al.
Frontiers in Materials (2022) Vol. 9
Open Access | Times Cited: 1
Maria Victoria Hangad, Sarah Keshvani, Niya Kelpin, et al.
Frontiers in Materials (2022) Vol. 9
Open Access | Times Cited: 1
A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events forpaxlovid and molnupiravir
Chao Yuan, Guisen Yin, Guiling Song, et al.
Research Square (Research Square) (2023)
Open Access
Chao Yuan, Guisen Yin, Guiling Song, et al.
Research Square (Research Square) (2023)
Open Access
Knowledge, attitude and practices towards SARS-CoV-2 genetic mutations and emerging variants among the population in Bangladesh: a cross-sectional study
Iftekhar Ahmed, Sadia Afruz Ether, Poushali Saha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e073091-e073091
Open Access
Iftekhar Ahmed, Sadia Afruz Ether, Poushali Saha, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e073091-e073091
Open Access
RNA polymerase inhibitor enisamium for treatment of moderate COVID-19 patients: a randomized, placebo-controlled, multicenter, double-blind phase 3 clinical trial
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Olga Holubovska, Pavlo Babich, Alla Mironenko, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Lifestyles of Palestinians during the COVID-19 pandemic: A cross-sectional study
Nihal Natour, Mariam Al-Tell
Nutrition and Health (2022), pp. 026010602211376-026010602211376
Open Access
Nihal Natour, Mariam Al-Tell
Nutrition and Health (2022), pp. 026010602211376-026010602211376
Open Access
